Sigyn Therapeutics(SIGY)
$0.030.00 (0.00%)
SIGY
Sigyn Therapeutics financials statements
$0.03
At close:0.00 (0.00%)
Want to see SIGY full AI Analyst Report?
Sigyn Therapeutics (SIGY) Income Statement
14 Followers
Sigyn Therapeutics Income Statement
Last quarter (Q1 2026), Sigyn Therapeutics's total revenue was $0.00. In Q1, Sigyn Therapeutics's net income was $-922.56K. See Sigyn Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.36K | $ -5.61K | $ -8.86K | $ -10.45K | ― | |
| $ 1.78M | $ 2.52M | $ 2.46M | $ 2.15M | $ 2.01M | |
| Depreciation and Amortization | $ 1.36K | $ 5.61K | $ 8.86K | $ 10.45K | $ 19.15K |
| $ -1.78M | $ -3.33M | $ -2.45M | $ -2.14M | $ -2.53M | |
| $ -1.79M | $ -2.52M | $ -2.46M | $ -2.15M | $ -2.01M | |
| $ -1.58M | $ -820.97K | $ -1.69M | $ -782.55K | $ -996.40K | |
| $ -3.36M | $ -3.34M | $ -4.15M | $ -2.93M | $ -3.00M | |
| $ -3.36M | $ -3.34M | $ -4.15M | $ -3.71M | $ -3.40M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.09 | $ -2.51 | $ -3.77 | $ -3.97 | $ -0.09 |
| Diluted EPS | $ -2.09 | $ -2.51 | $ -3.77 | $ -3.97 | $ -0.09 |
| Weighted Average Shares Outstanding | 1.61M | 1.33M | 1.10M | 934.00K | 36.40M |
| Weighted Average Shares Outstanding (Diluted) | 1.61M | 1.33M | 1.10M | 934.00K | 36.40M |
Currency in USD
